News at a glance

Downloads
Media inquiries & contact
Media inquiries & contact
Subscribe to press releases
News

A new gem joins the network: Galenica acquires Bären Apotheke am Zytglogge

The long-established Bären Apotheke am Zytglogge has been part of Bern’s cityscape for generations. Since 1 September 2026, it has been part of the Galenica network and continues to operate under the name “Bären Vita Zytglogge” with a new concept. This preserves a piece of Bern’s history while opening up new prospects for its future.

View post
 
Story

Creating New Spaces in Harmony with Our Culture

The world of work is constantly evolving, and Galenica is evolving with it. As part of our transformation, we are actively shaping the future. This is reflected not only in the way we collaborate, but also in the environments in which we work.

 
Ad hoc announcement

Galenica maintains its track record of consistent growth

Galenica increases sales by 7.1% to CHF 2,136.5 million in the first half of 2026. Adjusted1 EBIT increases by 7.1% to CHF 117.7 million.

 
News

Change in the Executive Committee of Labor Team

Alain M. Cahen will step down as CEO of Labor Team at the end of June 2026 and will also leave the Executive Committee. COO Thomas Brinkmann will take over on an interim basis.

 
 
Story

Coordinated basic care: From pilot projects to system solutions

Collaboration between different healthcare providers is already being tested in numerous pilot projects. One recent example is the Baselland supply model, which also involves participation from pharmacies in the Galenica network. The task going forward is to develop these approaches systematically and translate them into sustainable, broad-based system solutions. Daniele Madonna, Chief Pharmacies Category Management & Health Services, called for this step at this year’s Healthcare Professionals Initiative on 5 June 2026.

 
 
News

Sun Store Renens: First pharmacy in Western Switzerland to introduce the new concept

With the redesigned Sun Store pharmacy in Renens (VD), the first pharmacy in Western Switzerland is opening with a completely new concept. It places a strong focus on personalised advice, healthcare services and the overall customer experience. The aim is to further improve people’s access to low-threshold primary care services.

 
Ad hoc announcement

Galenica posts strong sales growth in a challenging market environment

Galenica achieves sales growth of 7.3% to CHF 1,409.7 million in the first four months of 2026. The main driver is strong growth in the pharmacy business and wholesale.

 
Press release

Healthcare players seek to establish the “Electronic Prescription Switzerland” service nationwide

FMH, pharmaSuisse and numerous industry representatives are working together to ensure that the “Electronic Prescription Switzerland” service is introduced and u

 
Press release

Annual General Meeting of Galenica Ltd. passes all motions and approves dividend of CHF 2.50 per share

All motions of the Board of Directors were approved with broad consensusThe Annual General Meeting re-elected all members of the Board of DirectorsA dividend of CHF

 
Press release

Consultation process at Bichsel completed

Bichsel decides to close its pharmaceutical manufacturing operations after the completion of the consultation process.

 
Ad hoc announcement

Galenica achieves strong annual result and increases mid-term guidance

Galenica increases sales in 2025 by 5.5% to CHF 4,135.6 million – all business areas contribute to growth.Adjusted1 EBIT increases by 11.3% to CHF 234.8 million.

 
Ad hoc announcement

Galenica focuses Bichsel’s business on home care services

Bichsel intends to discontinue pharmaceutical production by the end of 2026 at the latest for economic reasons. This affects up to 170 jobs.

 
Ad hoc announcement

Galenica continues to grow: sales increase to over CHF 4 billion

Sales up by 5.5% to CHF 4,135.

 
Story

700 medicines are missing: How supply works despite shortages

What to do if an important medication is missing? Supply bottlenecks have long been part of everyday life in Swiss pharmacies. How Galenica is helping to secure supply in Switzerland.

 
Press release

Galenica further expands online offering and acquires majority stake in Puravita

Galenica increases its investment in Puravita to 80% and further expands its digital presence.

 
 
Story

Hybrid healthcare services – a key element of tomorrow’s healthcare

What will healthcare look like in the future? This question is of concern not only to the Federal Council as part of its “Health2030” strategy, but also to universities, health insurers – and us as the leading network in the Swiss healthcare market.

 
Story

Vacci­nations in the pharmacy: A look behind the scenes

Vaccinations expand the duties of pharmacy staff and brings tangible benefits for the population and healthcare system – as a visit to the Amavita pharmacy in Storchengässchen in Bern shows.

 
Press release

Galenica successfully places a bond of over CHF 250 million

Today, Galenica successfully placed a fixed rate bond of over CHF 250 million. The bond has a term of 7 years and an annual coupon of 1.08%.

 
Ad hoc announcement

Galenica remains on growth track

Galenica Group sales grew 4.7% to CHF 2,999.7 million in the third quarter of 2025.Sales growth is driven by prescription drugs and dietary supplements.

 
Press release

Galenica strengthens basic care with new pharmacy concept

Pharmacies play a key role in healthcare.

 
News

HomeCare Bichsel and Lifestage Solutions: Working together for unique home care services

Galenica offers a unique range of services for retirement and nursing homes and home care organisations, hospitals and medical practices throughout Switzerland. These include the fully automated ordering and billing of consumables and care products via Lifestage Solutions as well as Bichsel’s specialised home care services. Our goal as a network: Significantly relieve the burden on nursing staff through digital solutions and specialist expertise.

 
Press release

Launch of Galenica Diagnostics: Acquisition of Labor Team completed

Labor Team will become part of the Galenica network once the acquisition is complete.

 
 
News

40 years of Spagyros: tradition meets modernity

Tradition or innovation? For the last 40 years, the answer at Spagyros has been: both. Ancient healing knowledge and cutting-edge research go hand in hand here. CEO Michael Severus explains how this balance is struck.

 
Ad hoc announcement

Galenica demonstrates pleasing growth and improves EBIT guidance

Galenica Group sales grew by 5.0% to CHF 1,995.4 million in the first half of 2025.Adjusted EBIT1 increased by 10.9% to CHF 109.

 
News

New internal appointment of General Counsel and Secretary General

Barbara Wälchli, General Counsel and Secretary General, has decided to leave Galenica at the end of 2025. With Cécile Matter as the new General Counsel and Jürg Pauli as the future Secretary General of the Board of Directors, two experienced executives from within the company are taking over the reins.

 

Shaping tomorrow's healthcare system together.

News Megatrends

Our latest videos

Media inquiries & contact

Are you a journalist or editor and have questions about Galenica? Get in touch with us.

Media inquiries & contact

Media centre

Images, videos, logos: All downloads for reuse in media reports.

Media centre

Information for investors

Invest in the strongest network in the Swiss healthcare market.

Here you will find information about our share price, as well as presentations, conferences and our financial calendar.

Investors